HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fragrance allergens

This article was originally published in The Rose Sheet

Executive Summary

Labeling of "known allergens" or "toxic substances" would be required under House bill reintroduced by Rep. Jan Schakowsky (D-Ill.) May 22. Referred to House Energy & Commerce Committee, HR 1947 would amend FD&C Act to include language requiring manufacturers to conduct pre-market product testing to ensure proper labeling of fragrances containing allergens or toxins. Schakowsky initially introduced bill last September (1"The Rose Sheet" Oct. 2, 2000, In Brief). Similar efforts in Europe could engender more attention stateside; an amendment to the Cosmetics Directive that would require labeling of 26 ingredients identified as allergens was approved by European Parliament in early April (2"The Rose Sheet" April 9, p. 12). Seventh Amendment is being reviewed by Council of Ministers working group

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009285

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel